| 2012-2013 |
President, Cancer Biology Training Consortium |
| 2010-2013 |
Board of Directors, Cancer Biology Training Consortium |
| 2010 |
Consultant, Bristol-Myers Squibb |
| 2010 |
Consultant, AstraZeneca |
| 2010 |
Consultant, Sanofi-Aventis |
| 2010-2012 |
Chair, Pancreatic Cancer Action Network– AACR Innovative Grants Scientific Review Committee |
| 2010-2011 |
AACR Program Committee |
| 2009-present |
Editorial Board, Bioscience Reports |
| 2009-present |
Editorial Board, Small GTPases |
| 2009-present |
Editorial Board, Genes & Cancer |
| 2008 |
Senior Academic Visitor of Wolfson College, Cambridge, UK |
| 2008-present |
Scientific Advisory Board, Lustgarten Foundation for Pancreatic Cancer Research |
| 2008-present |
Consultant, Millipore |
| 2001-2011 |
Reviewer, Italian Association Cancer Research |
| 2007-2008 |
AACR Program Committee |
| 2007-2008 |
Member, Children’s Tumor Foundation, Drug Discovery Initiative Panel |
| 2007 |
Member, AACR Grants Subcommittee for Pancreatic Research Fellowship |
| 2006-2009 |
Member, DOD Neurofibromatosis Research Program Integration Panel |
| 2006- present |
Editorial Board, Journal Molecular Signaling |
| 2004-2007 |
AACR Laboratory Research Awards Selection Committee |
| 2005- present |
Member, Cancer Biology Training Consortium |
| 2003 |
Consultant, Chemicon |
| 2003 |
Consultant, Upstate Biotechnology |
| 2003 |
Consultant, Odyssey Thera |
| 2002 |
Consultant, PPD Discovery |
| 2002-present |
Member, Faculty of 1000 |
| 2001 |
External Reviewer, Wake Forest Cancer Center Program |
| 2000-2002 |
Associate Editor, Cancer Research |
| 2000-present |
Editorial Board, Cancer Letters |
| 2000-present |
Consultant, Tularik |
| 1998-present |
Director, NIH Cancer Cell Biology Training Grant |
| 1998-present |
Board of Advisors, Children’s Tumor Foundation |
| 1998-present |
Member, Curriculum in Toxicology, UNC-Chapel Hill |
| 1998 |
Consultant, Schering-Plogh |
| 1997 |
Consultant, Dupont-Merck |
| 1996-1997 |
Consultant, Biomeasure |
| 1996 |
Consultant, Merck |
| 1995-1996 |
Consultant, Parke-Davis |
| 1995-present |
Professor, Department of Pharmacology Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill |
| 1992-1995 |
Associate Professor, Department of Pharmacology Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill |
| 1992-1996 |
Member, NIH Pathology B Study Section |
| 1992-1994 |
Consultant, Bristol-Myers Squibb |
| 1992-1993 |
Consultant, Dupont Merck Pharmaceuticals |
| 1991-1993 |
Consultant, Eisai Research Institute |
| 1990-present |
Consultant, Special Review Committee, NCI |
| 1989-1991 |
Ad Hoc Member, NIH Pathology B Study Section |
| 1989-1992 |
Staff Scientist, The Burnham Institut |
| 1985-1989 |
Assistant Staff Scientist, The Burnham Institute |
| 1981-1985 |
Postdoctoral Fellow, Harvard Medical School and the Dana-FarberPostdoctoral Fellow, Harvard Medical School and the Dana-Farber Cancer Institute |
Der Lab 